Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$221.91 USD
+0.66 (0.30%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $221.89 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$221.91 USD
+0.66 (0.30%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $221.89 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Zacks News
Brown & Brown (BRO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Brown & Brown (BRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Marsh & McLennan (MMC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Focuses to Boost Hold in Australia
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer pursues twin growth-related initiatives to establish a solid hold on the superannuation market of Australia and expand its investment capabilities.
Arthur J. Gallagher (AJG) Closes Buck Buyout, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher (AJG) bought partnership interest in BCHR Holdings, L.P., dba Buck and its subsidiaries for $660 million to consolidate its portfolio of professional services.
Why Marsh & McLennan (MMC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Brown & Brown (BRO) Boosts Canada Presence With HBG Buyout
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Highcourt Partners is likely to provide it solid opportunities and a robust leadership team to boost growth in Canada.
Arthur J. Gallagher (AJG) Boosts Surety Market With Viking Bond
by Zacks Equity Research
The addition of Viking Bond Service to Arthur J. Gallagher's (AJG) portfolio is likely to enhance its existing surety offerings and boost its expertise in the surety market.
Aon (AON) Stock Jumps 4.6%: Will It Continue to Soar?
by Zacks Equity Research
Aon (AON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Arthur J. Gallagher and Ryan Specialty Holdings
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher and Ryan Specialty Holdings have been highlighted in this Industry Outlook article.
4 Insurance Brokers to Watch Despite Industry Challenges
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, AJG and RYAN.
Arthur J. Gallagher (AJG) Boosts Portfolio With Bay Risk
by Zacks Equity Research
The addition of Bay Risk to Arthur J. Gallagher's (AJG) portfolio is going to drive the expanding global programs practice of Gallagher Re.
After Plunging -7.66% in 4 Weeks, Here's Why the Trend Might Reverse for Marsh & McLennan (MMC)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Marsh & McLennan (MMC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
AON Unit Launches New IP-Backed Lending Investment Vehicle
by Zacks Equity Research
AON unveils a new investment vehicle to help IT companies secure Intellectual Property backed funds.
Marsh & McLennan (MMC) Unit Buys Digital HR Firm Leapgen
by Zacks Equity Research
The Leapgen buyout is expected to enable Marsh & McLennan's (MMC) business, Mercer, to provide better HR digital solutions that can improve return on investment and utilization.
eHealth (EHTH) Q4 Earnings Top, Approved Members Fall Y/Y
by Zacks Equity Research
eHealth (EHTH) Q4 results reflect lower operating costs and expenses. However, revenues declined and so did approved members.
The Zacks Analyst Blog Highlights Apple, Linde, Marsh & McLennan Companies, GSK and Expedia
by Zacks Equity Research
Apple, Linde, Marsh & McLennan Companies, GSK and Expedia are included in this Analyst Blog.
Top Analyst Reports for Apple, Linde & Marsh & McLennan
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Linde plc (LIN) and Marsh & McLennan Companies, Inc. (MMC).
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Factors That Make Marsh & McLennan (MMC) Stock A Lucrative Bet
by Zacks Equity Research
Marsh & McLennan (MMC) remains well-poised for growth on the back of solid contributions from business units. Strong cash-generating abilities is another tailwind for the stock.
Marsh & McLennan (MMC) Q4 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results reflect sound contributions from the Consulting segment and well-performing international operations, partly offset by escalating operating costs.
Marsh & McLennan (MMC) Q4 Earnings Top Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 5% and 4.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q4 Earnings on Jan 26: AJG, MMC and WRB
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to aid fourth-quarter results of insurers like AJG, MMC and WRB. However, an active catastrophe environment is likely to have weighed on insurers' performance.
Why Marsh & McLennan (MMC) Might Surprise This Earnings Season
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Marsh & McLennan (MMC) Sustain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect solid segmental performances, partly offset by elevated compensation and benefits expenses.
The Zacks Analyst Blog Highlights Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson
by Zacks Equity Research
Exxon Mobil, Fomento Economico Mexicano, Prologis, Marsh & McLennan and Becton Dickinson are part of the Zacks top Analyst Blog.